Blockage of Cholinergic Signaling via Muscarinic Acetylcholine Receptor 3 Inhibits Tumor Growth in Human Colorectal Adenocarcinoma

SIMPLE SUMMARY: Darifenacin is a selective muscarinic acetylcholine receptor 3 (M3R) antagonist in clinical use for benign bladder disorders. Here, the effects of M3R blockage by darifenacin on human colon adenocarcinoma cells are analyzed in vitro and in vivo. M3R expression was found in the majori...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancers (Basel)
Main Authors: Hering, Nina A., Liu, Verena, Kim, Rayoung, Weixler, Benjamin, Droeser, Raoul A., Arndt, Marco, Pozios, Ioannis, Beyer, Katharina, Kreis, Martin E., Seeliger, Hendrik
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2021
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8267754/
https://ncbi.nlm.nih.gov/pubmed/34203220
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13133220
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados